...
首页> 外文期刊>Therapeutic Drug Monitoring >High-performance liquid chromatography-mass spectroscopy/mass spectroscopy method for simultaneous quantification of total or free fraction of mycophenolic acid and its glucuronide metabolites.
【24h】

High-performance liquid chromatography-mass spectroscopy/mass spectroscopy method for simultaneous quantification of total or free fraction of mycophenolic acid and its glucuronide metabolites.

机译:高效液相色谱-质谱/质谱法同时定量麦考酚酸及其葡糖醛酸苷代谢物的总或游离级分。

获取原文
获取原文并翻译 | 示例

摘要

Measurement of unbound fractions of mycophenolic acid and its metabolites may prove useful in explaining the complicated pharmacokinetic and pharmacodynamic behavior of this drug as well as in therapeutic drug monitoring. We developed a reliable, accurate, and sensitive liquid chromatography-tandem mass spectrometric method for the simultaneous quantification of mycophenolic acid (MPA), MPA glucuronide (MPAG), and MPA acyl-glucuronide (AcMPAG), total or unbound, in plasma, urine, and tissue extract. This method uses a single internal standard, carboxy-butoxy ether of mycophenolic acid (MPAC), and involves a simple sample preparation step. Aliquots of plasma, urine, or dissolved tissue extract (100 microL) or plasma ultrafiltrate for free analytes (50 microL) are treated with acetonitrile/formic acid mixture (99.5/0.5 v/v) followed by centrifugation and dilution with water. The prepared samples are then injected onto an extraction column (Eclipse XDB-C18 12.5 x 4.1 mm; Agilent Technologies, Palo Alto, CA) and washed with mobile phase composed of acetonitrile/water/formic acid (10/89.5/0.5 v/v/v) at a flow rate of 2.8 mL/min. A switching valve is activated 1 minute after sample injection. The analytes are eluted onto the analytical column (Eclipse XDB-C18 150 x 4.1 mm; Agilent Technologies) with a gradient of 0.5% aqueous formic acid, methanol, acetonitrile, and water. We used a tandem mass spectrometer with electrospray ion source, in which the tandem mass spectroscopy transitions were (m/z): 338-->207 for MPA, 438-->303 for MPAC, and 514-->303 for MPAG and AcMPAG. The dynamic ranges (lower limit of quantitation and upper limit of quantitation) were as follows: 0.05 to 30 mg/L for total MPA and 1 to 300 microg/L for free MPA; 0.5 to 300 mg/L of total MPAG and 0.2 to 60 mg/L for free MPAG; and 0.025 to 15 mg/L of total AcMPAG and 1 to 60 microg/L for free AcMPAG. The precision at lower limit of quantitation was in the range of 8.0% to 11.9% for all three total analytes and 13.8 to 18.7% for the free analytes. Accuracy at lower limit of quantitation was in the range of 100% to 105% for total and 97% to 99% for free analytes. Between-day precision of quality control samples was 4.0% to 6.3% for human plasma spiked with total analytes and 4.5% to 14.4% for spiked plasma ultrafiltrate for free analytes. Mean absolute recovery ranged from 98.5% to 101.7% for MPA (both total and free), from 78.1% to 103.4% for MPAG and from 91.5% to 110.4% for AcMPAG. No significant ion suppression was found under these conditions for any of the analytes. Carryover effect was found to be at a maximum level of 0.02%. This method was successfully applied to analyze over 11,000 samples for total analytes, and over 8000 samples for free analytes in plasma, and has been in operation for nearly 3 years without loss of performance.
机译:麦考酚酸及其代谢产物的未结合部分的测量可能证明对解释这种药物的复杂药代动力学和药效学行为以及治疗药物监测很有用。我们开发了一种可靠,准确且灵敏的液相色谱-串联质谱方法,用于同时定量测定血浆,尿液中的全部或未结合的麦考酚酸(MPA),MPA葡糖醛酸(MPAG)和MPA酰基葡糖苷酸(AcMPAG)。和组织提取物。此方法使用单一内标麦考酚酸(MPAC)的羧基丁氧基醚,涉及简单的样品制备步骤。用乙腈/甲酸混合物(99.5 / 0.5 v / v)处理血浆,尿液或溶解的组织提取物(100 microL)或血浆超滤液的等分试样,以分离游离分析物(50 microL),然后离心并用水稀释。然后将准备好的样品注射到萃取柱(Eclipse XDB-C18 12.5 x 4.1 mm; Agilent Technologies,Palo Alto,CA)上并用乙腈/水/甲酸(10 / 89.5 / 0.5 v / v)组成的流动相洗涤/ v)的流速为2.8 mL / min。进样后1分钟激活一个切换阀。将分析物用0.5%的甲酸水溶液,甲醇,乙腈和水梯度洗脱到分析柱(Eclipse XDB-C18 150 x 4.1 mm; Agilent Technologies)上。我们使用了带电喷雾离子源的串联质谱仪,其中串联质谱的跃迁为(m / z):MPA为338-> 207,MPAC为438-> 303,MPAG为514-> 303 AcMPAG。动态范围(定量下限和定量上限)如下:总MPA为0.05至30 mg / L,游离MPA为1至300 microg / L; 0.5至300毫克/升的总MPAG和0.2至60毫克/升的免费MPAG;总AcMPAG为0.025至15 mg / L,游离AcMPAG为1至60 microg / L。对于所有三种总分析物,定量下限下的精密度均在8.0%至11.9%范围内,对于游离分析物,其精度在13.8至18.7%范围内。定量下限的准确度范围为总计100%至105%,游离分析物为97%至99%。对于加有总分析物的人血浆,质量控制样品的日间精密度为4.0%至6.3%,对于游离分析物的加标血浆超滤液,其日间精度为4.5%至14.4%。 MPA的平均绝对回收率从98.5%到101.7%(全部和免费),MPAG的平均绝对回收率从78.1%到103.4%,AcMPAG的平均绝对回收率从91.5%到110.4%。在这些条件下,对于任何分析物都没有发现明显的离子抑制作用。发现残留效应最大为0.02%。该方法已成功应用于分析11,000多个样品中的总分析物,以及8000多个样品中的血浆中的游离分析物,并且已经运行了近3年而没有损失性能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号